Genomatix Software GmbH today announced that it has achieved GeneChip-compatible TM status for several products with the Affymetrix Inc. (Nasdaq: AFFX) GeneChip® microarray platform and that it has ...
Affymetrix, Inc. and Lineagen, Inc. announced the companies have signed an agreement to incorporate Affymetrix' GeneChip® technology into Lineagen's next-generation FirstStepDx, a genetic evaluation ...
Genomatix announced today that Bayer HealthCare licensed Genomatix microarray analysis platform ChipInspector. ChipInspector enables biologists and bio-informaticians to analyze chip raw data from ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix (Nasdaq:AFFX) and Ariosa Diagnostics, Inc. today announced the signing of a multi-year supply agreement covering Affymetrix arrays and instruments to ...
OXFORD, England--(BUSINESS WIRE)--Cytox Ltd, an innovative developer of assays for risk assessment and prediction of dementia, and Affymetrix (Nasdaq:AFFX), a leading provider of translational ...
Microarray giant Affymetrix has updated two of its more popular expression sets. With the release of the GeneChip ® Mouse Expression Set 430 and Rat Expression Set 230, the company now provides "the ...
Agencourt Bioscience, a wholly-owned subsidiary of Beckman Coulter (BEC), NuGEN Technologies, and Affymetrix Clinical Services Laboratory announce a collaboration that has yielded a service offering ...
Genomatix Software GmbH has announced that it has achieved GeneChip-compatible™ status for several products with the Affymetrix Inc. GeneChip ® microarray platform and that it has joined Affymetrix ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results